MISSISSAUGA, ON, Jan. 14, 2021 /PRNewswire/ - Nuvo Pharmaceuticals
Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or
the Company), a Canadian focused healthcare company with global
reach and a diversified portfolio of commercial products, today
announced it will host an investor presentation webcast on
Thursday, January 28 at 2:00 p.m. EST (11:00 a.m.
PST).
During the webcast, Jesse Ledger,
Miravo's President & Chief Executive Officer will provide a
PowerPoint presentation that will cover key areas of Miravo's
business. During the presentation, investors will have an
opportunity to ask questions through an interactive Q&A
portal.
To access the webcast or to ask questions during the live event,
please pre-register at the following link:
https://event.webcasts.com/starthere.jsp?ei=1419796&tp_key=e642921200
An archived version of the webcast and presentation will be
available on the Presentations & Webcasts page of the Company's
website,
https://www.miravohealthcare.com/investors/presentations-webcasts/ following
the event.
About Miravo Healthcare
Miravo is a Canadian focused, healthcare company with global
reach and a diversified portfolio of commercial products. The
Company's products target several therapeutic areas, including
pain, allergy, and dermatology. The Company's strategy is to
in-license and acquire growth-oriented, complementary products for
Canadian and international markets. Miravo's head office is located
in Mississauga, Ontario, Canada,
the international operations are located in Dublin, Ireland and the Company's
manufacturing facility is located in Varennes, Québec, Canada. The Varennes facility operates in a Good
Manufacturing Practices (GMP) environment respecting the U.S,
Canada and E.U. GMP regulations
and is regularly inspected by Health Canada and the U.S. Food and
Drug Administration. For additional information, please visit
www.miravohealthcare.com.
Forward-Looking Statements
This press release
contains "forward-looking information" as defined under Canadian
securities laws (collectively, "forward-looking statements"). The
words "plans", "expects", "does not expect", "goals", "seek",
"strategy", "future", "estimates", "intends", "anticipates", "does
not anticipate", "projected", "believes" or variations of such
words and phrases or statements to the effect that certain actions,
events or results "may", "will", "could", "would", "should",
"might", "likely", "occur", "be achieved" or "continue" and similar
expressions identify forward-looking statements. In addition, any
statements that refer to expectations, intentions, projections or
other characterizations of future events or circumstances contain
forward-looking statements.
Forward-looking statements are not historical facts but
instead represent management's expectations, estimates and
projections regarding future events or circumstances, including the
anticipated receipt of certain milestone and royalty payments, the
anticipated launch of certain products and the potential impact of
COVID-19. Such forward-looking statements are qualified in their
entirety by the inherent risks, uncertainties and changes in
circumstances surrounding future expectations which are difficult
to predict and many of which are beyond the control of the Company.
Forward-looking statements are necessarily based on a number of
estimates and assumptions that, while considered reasonable by
management of the Company as of the date of this press release, are
inherently subject to significant business, economic and
competitive uncertainties and contingencies and may prove to be
incorrect. Material factors and assumptions used to develop the
forward-looking statements, and material risk factors that could
cause actual results to differ materially from the forward-looking
statements, include but are not limited to, the validity of the
'907 and '285 Patents claims, the outcome of ongoing patent
litigation, the potential impact of COVID-19 on the Company's
operations, business and financial results and other factors, many
of which are beyond the control of Miravo. Additional factors that
could cause Miravo's actual results and financial condition to
differ materially from those indicated in the forward-looking
statements include, among others, the risk factors included in
Miravo's most recent Annual Information Form dated February 24, 2020 under the heading "Risks
Factors", and as described from time to time in the reports and
disclosure documents filed by Miravo with Canadian securities
regulatory agencies and commissions. These and other factors should
be considered carefully and readers should not place undue reliance
on Miravo's forward-looking statements. Forward-looking statements
should not be read as guarantees of future performance or results
and will not necessarily be accurate indications of whether or not
the times at or by which such performance or results will be
achieved.
All forward-looking statements are based only on information
currently available to the Company and are made as of the date of
this press release. Except as expressly required by applicable
Canadian securities law, the Company assumes no obligation to
publicly update or revise any forward-looking statement, whether as
a result of new information, future events or otherwise. All
forward-looking statements in this press release are qualified by
these cautionary statements.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/miravo-healthcare-to-host-investor-webcast-on-january-28-2021-at-200-pm-est-301208032.html
SOURCE Nuvo Pharmaceuticals Inc.